Minimal residue disease detection in early-stage breast cancer: a review

Over the past five years, circulating tumor DNA (ctDNA) testing has emerged as a game-changer in cancer research, serving as a less invasive and highly sensitive method to monitor tumor dynamics. CtDNA testing has a wide range of potential applications in breast cancer (BC) management, including dia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular biology reports 2025-12, Vol.52 (1), p.106, Article 106
Hauptverfasser:	Zhang, Yuan, Yuan, Xiaoying
Format:	Artikel
Sprache:	eng
Schlagworte:	Animal Anatomy Animal Biochemistry Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Biomedical and Life Sciences Breast cancer Breast Neoplasms - blood Breast Neoplasms - diagnosis Breast Neoplasms - genetics Breast Neoplasms - therapy Chemotherapy Circulating Tumor DNA - blood Circulating Tumor DNA - genetics Early Detection of Cancer - methods Female Histology Humans Life Sciences Morphology Neoadjuvant Therapy - methods Neoplasm Recurrence, Local - blood Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - genetics Neoplasm Staging Neoplasm, Residual - blood Neoplasm, Residual - diagnosis Neoplasm, Residual - genetics Prognosis Review Sensitivity analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!